Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 346

1.

The Immune Landscape of Cancer.

Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Mokrab Y, Newman AM, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CS; Cancer Genome Atlas Research Network, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich I.

Immunity. 2019 Aug 20;51(2):411-412. doi: 10.1016/j.immuni.2019.08.004. No abstract available.

PMID:
31433971
2.

Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma.

Calsina B, Castro-Vega LJ, Torres-Pérez R, Inglada-Pérez L, Currás-Freixes M, Roldán-Romero JM, Mancikova V, Letón R, Remacha L, Santos M, Burnichon N, Lussey-Lepoutre C, Rapizzi E, Graña O, Álvarez-Escolá C, de Cubas AA, Lanillos J, Cordero-Barreal A, Martínez-Montes ÁM, Bellucci A, Amar L, Fernandes-Rosa FL, Calatayud M, Aller J, Lamas C, Sastre-Marcos J, Canu L, Korpershoek E, Timmers HJ, Lenders JW, Beuschlein F, Fassnacht-Capeller M, Eisenhofer G, Mannelli M, Al-Shahrour F, Favier J, Rodríguez-Antona C, Cascón A, Montero-Conde C, Gimenez-Roqueplo AP, Robledo M.

Theranostics. 2019 Jul 9;9(17):4946-4958. doi: 10.7150/thno.35458. eCollection 2019.

3.

Heat Shock Protein 90 as a Prognostic Marker and Therapeutic Target for Adrenocortical Carcinoma.

Siebert C, Ciato D, Murakami M, Frei-Stuber L, Perez-Rivas LG, Monteserin-Garcia JL, Nölting S, Maurer J, Feuchtinger A, Walch AK, Haak HR, Bertherat J, Mannelli M, Fassnacht M, Korpershoek E, Reincke M, Stalla GK, Hantel C, Beuschlein F.

Front Endocrinol (Lausanne). 2019 Jul 19;10:487. doi: 10.3389/fendo.2019.00487. eCollection 2019.

4.

Eighteenth Conference on the Adrenal Cortex Munich, Germany June 25-27, 2018.

Schimmer BP, Beuschlein F, Fassnacht M, Reincke M, Rainey WE.

J Steroid Biochem Mol Biol. 2019 Aug 1;194:105444. doi: 10.1016/j.jsbmb.2019.105444. [Epub ahead of print] No abstract available.

PMID:
31377234
5.

Safety of medical adjustment and confirmatory testing in the diagnostic workup of primary aldosteronism.

Heinrich DA, Adolf C, Quinkler M, Holler F, Lechner B, Nirschl N, Sturm L, Görge V, Beuschlein F, Reincke M.

Eur J Endocrinol. 2019 Aug 1. pii: EJE-19-0138.R2. doi: 10.1530/EJE-19-0138. [Epub ahead of print]

PMID:
31376812
6.

Pheochromocytoma and paraganglioma: Clinical feature based disease probability in relation to catecholamine biochemistry and reason for disease suspicion.

Geroula A, Deutschbein T, Langton K, Masjkur JR, Pamporaki C, Peitzsch M, Fliedner S, Timmers HJ, Bornstein SR, Beuschlein F, Stell A, Januszewicz A, Prejbisz A, Fassnacht M, Lenders J, Eisenhofer G.

Eur J Endocrinol. 2019 Aug 1. pii: EJE-19-0159.R2. doi: 10.1530/EJE-19-0159. [Epub ahead of print]

PMID:
31370000
7.

Synergistic Highly Potent Targeted Drug Combinations in different Pheochromocytoma Models including Human Tumor Cultures.

Fankhauser M, Bechmann N, Lauseker M, Goncalves J, Favier J, Klink B, William D, Gieldon L, Maurer J, Spöttl G, Rank P, Knösel T, Orth M, Ziegler CG, Aristizabal Prada ET, Rubinstein G, Fassnacht M, Spitzweg C, Grossman AB, Pacak K, Beuschlein F, Bornstein SR, Eisenhofer G, Auernhammer CJ, Reincke M, Nölting S.

Endocrinology. 2019 Jul 19. pii: en.2019-00410. doi: 10.1210/en.2019-00410. [Epub ahead of print]

PMID:
31322702
8.

THERAPY OF ENDOCRINE DISEASE: Medical treatment of primary aldosteronism.

Lechner B, Lechner K, Heinrich DA, Adolf C, Holler F, Schneider H, Beuschlein F, Reincke M.

Eur J Endocrinol. 2019 Jul 1. pii: EJE-19-0215.R1. doi: 10.1530/EJE-19-0215. [Epub ahead of print] Review.

PMID:
31299637
9.

Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma.

Assié G, Jouinot A, Fassnacht M, Libé R, Garinet S, Jacob L, Hamzaoui N, Neou M, Sakat J, de La Villéon B, Perlemoine K, Ragazzon B, Sibony M, Tissier F, Gaujoux S, Dousset B, Sbiera S, Ronchi CL, Kroiss M, Korpershoek E, De Krijger R, Waldmann J, Quinkler M, Haissaguerre M, Tabarin A, Chabre O, Luconi M, Mannelli M, Groussin L, Bertagna X, Baudin E, Amar L, Coste J, Beuschlein F, Bertherat J.

JAMA Oncol. 2019 Jul 11. doi: 10.1001/jamaoncol.2019.1558. [Epub ahead of print]

PMID:
31294750
10.

Somatic PRKACA mutations: association with transition from pituitary-dependent to adrenal-dependent Cushing's syndrome.

Di Dalmazi G, Timmers HJLM, Arnaldi G, Küsters B, Scarpelli M, Bathon K, Calebiro D, Beuschlein F, Hermus A, Reincke M.

J Clin Endocrinol Metab. 2019 Jul 5. pii: jc.2018-02209. doi: 10.1210/jc.2018-02209. [Epub ahead of print]

PMID:
31276155
11.

Adrenal insufficiency after unilateral adrenalectomy in primary aldosteronism - long-term outcome and clinical impact.

Heinrich DA, Adolf C, Holler F, Lechner B, Schneider H, Riester A, Nirschl N, Sturm L, Wang X, Ladurner R, Seidensticker M, Bidlingmaier M, Beuschlein F, Reincke M.

J Clin Endocrinol Metab. 2019 Jun 21. pii: jc.2019-00996. doi: 10.1210/jc.2019-00996. [Epub ahead of print]

PMID:
31225874
12.

Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches.

Gieldon L, William D, Hackmann K, Jahn W, Jahn A, Wagner J, Rump A, Bechmann N, Nölting S, Knösel T, Gudziol V, Constantinescu G, Masjkur J, Beuschlein F, Timmers HJ, Canu L, Pacak K, Robledo M, Aust D, Schröck E, Eisenhofer G, Richter S, Klink B.

Cancers (Basel). 2019 Jun 11;11(6). pii: E809. doi: 10.3390/cancers11060809.

13.

Adrenocortical carcinoma - towards genomics guided clinical care.

Crona J, Beuschlein F.

Nat Rev Endocrinol. 2019 Sep;15(9):548-560. doi: 10.1038/s41574-019-0221-7. Review.

PMID:
31147626
14.

Treatment of Primary Aldosteronism with mTORC1 Inhibitors.

Trinh B, Hepprich M, Betz MJ, Burkard T, Cavelti-Weder C, Seelig E, Meienberg F, Kratschmar DV, Beuschlein F, Reincke M, Odermatt A, Hall MN, Donath MY, Swierczynska MM.

J Clin Endocrinol Metab. 2019 May 14. pii: jc.2019-00563. doi: 10.1210/jc.2019-00563. [Epub ahead of print]

PMID:
31087053
15.

The TALE homeodomain of PBX1 is involved in human primary testis-determination.

Eozenou C, Bashamboo A, Bignon-Topalovic J, Merel T, Zwermann O, Lourenco D, Lottmann H, Lichtenauer U, Rojo S, Beuschlein F, McElreavey K, Brauner R.

Hum Mutat. 2019 Aug;40(8):1071-1076. doi: 10.1002/humu.23780. Epub 2019 May 21.

PMID:
31058389
16.

Daily adjustment of glucocorticoids by patients with adrenal insufficiency.

Schöfl C, Mayr B, Maison N, Beuschlein F, Meyer G, Badenhoop K, Kienitz T, Quinkler M.

Clin Endocrinol (Oxf). 2019 Aug;91(2):256-262. doi: 10.1111/cen.14004. Epub 2019 May 16.

PMID:
31050815
17.

Therapeutic options after surgical failure in Cushing's disease: A critical review.

Rubinstein G, Osswald A, Zopp S, Ritzel K, Theodoropoulou M, Beuschlein F, Reincke M.

Best Pract Res Clin Endocrinol Metab. 2019 Apr 16:101270. doi: 10.1016/j.beem.2019.04.004. [Epub ahead of print] Review.

PMID:
31036383
18.

Plasma steroid profiles in subclinical compared to overt adrenal Cushing's syndrome.

Masjkur J, Gruber M, Peitzsch M, Kaden D, Di Dalmazi G, Bidlingmaier M, Zopp S, Langton K, Fazel J, Beuschlein F, Bornstein SR, Reincke M, Eisenhofer G.

J Clin Endocrinol Metab. 2019 Apr 12. pii: jc.2018-02349. doi: 10.1210/jc.2018-02349. [Epub ahead of print]

PMID:
30977834
19.

Performance of LC-MS/MS and immunoassay based 24-h urine free cortisol in the diagnosis of Cushing's syndrome.

Oßwald A, Wang R, Beuschlein F, Hartmann MF, Wudy SA, Bidlingmaier M, Zopp S, Reincke M, Ritzel K.

J Steroid Biochem Mol Biol. 2019 Jun;190:193-197. doi: 10.1016/j.jsbmb.2019.04.004. Epub 2019 Apr 5.

PMID:
30959155
20.

Effects of chronically high levels of aldosterone on different cognitive dimensions: an investigation in patients with primary aldosteronism.

Engler L, Adolf C, Heinrich D, Brem AK, Riester A, Franke A, Beuschlein F, Reincke M, Steiger A, Künzel H.

Endocr Connect. 2019 Mar 1. pii: EC-19-0043.R1. doi: 10.1530/EC-19-0043. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center